ReviewFrontiers in endocrinology2020

Temozolomide Is a Potential Therapeutic Tool for Patients With Metastatic Pheochromocytoma/Paraganglioma-Case Report and Review of the Literature.

Anli Tong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.